David Albala, MD, discusses the key advantages of utilizing PSMA-PET screening in clinical practice for patients with prostate cancer.
David Albala, MD
Advertisement
Articles by David Albala, MD
David Albala, MD, urologist and medical director, Associated Medical Professionals, discusses patients with prostate cancer who are best suited to be treated with robotic surgery.
David Albala, MD, urologist and medical director, Associated Medical Professionals, discusses the benefits associated with robotic surgery in the treatment of patients with prostate cancer.
Advertisement
Latest Updated Articles
Dr. Albala on the Benefits of Robotic Surgery in Prostate CancerPublished: January 12th 2017 | Updated:
Dr. Albala on Patient Selection for Robotic Surgery in Prostate CancerPublished: February 9th 2017 | Updated:
Dr. David Albala on The Role of Robotic Surgery in Prostate CancerPublished: November 6th 2016 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
5